Dina Masi - Sep 20, 2023 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Chief Financial Officer
Signature
/s/ Dina L Masi
Stock symbol
INBP
Transactions as of
Sep 20, 2023
Transactions value $
$0
Form type
4
Date filed
9/21/2023, 10:51 AM
Previous filing
Nov 10, 2022
Next filing
Nov 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INBP Common Stock Award $4.5K +50K +51.44% $0.09* 147K Sep 20, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (right to buy) Disposed to Issuer -$4.5K -50K -7.98% $0.09* 577K Sep 20, 2023 Common Stock 50K $0.09 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.
F2 50,000 stock options disposed of upon exercise of the portion of a stock option grant dated June 2, 2015. 200,000 stock options for the right to purchase common stock at $0.09 remain available to exercise.